<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">JSLS</journal-id>
      <journal-id journal-id-type="iso-abbrev">JSLS</journal-id>
      <journal-id journal-id-type="hwp">jsls</journal-id>
      <journal-id journal-id-type="pmc">jsls</journal-id>
      <journal-id journal-id-type="publisher-id">JSLS</journal-id>
      <journal-title-group>
        <journal-title>JSLS : Journal of the Society of Laparoendoscopic Surgeons</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1086-8089</issn>
      <issn pub-type="epub">1938-3797</issn>
      <publisher>
        <publisher-name>Society of Laparoendoscopic Surgeons</publisher-name>
        <publisher-loc>Miami, FL</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21902959</article-id>
      <article-id pub-id-type="pmc">3134688</article-id>
      <article-id pub-id-type="publisher-id">10-04-068</article-id>
      <article-id pub-id-type="doi">10.4293/108680811X13022985131732</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Wandering <italic>Mirena</italic>: Laparoscopic Retrieval</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Erian</surname>
            <given-names>Mark</given-names>
          </name>
          <degrees>FRANZCOG, FRCOG, DM</degrees>
          <aff>High Doctorate of Medicine, University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McLaren</surname>
            <given-names>Glenda</given-names>
          </name>
          <degrees>FRANZCOG, FRCOG</degrees>
          <aff>Senior Consultant Obstetrician and Gynaecologist, Mater Mother's Hospital, Brisbane, Queensland, Australia.</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baartz</surname>
            <given-names>David</given-names>
          </name>
          <degrees>FRANZCOG</degrees>
          <aff>Senior Consultant Obstetrician and Gynaecologist, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp>Address correspondence to: A/Professor Mark Erian, 
<addr-line>6th Floor, Teaching and Research, Ned Hanlon Building, Royal Brisbane and Women's Hospital, Herston, Queensland 4029, Australia</addr-line>. Email: <email>m.erian1@uq.edu.au</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2011</year>
      </pub-date>
      <volume>15</volume>
      <issue>1</issue>
      <fpage>127</fpage>
      <lpage>130</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2011 by JSLS, Journal of the Society of Laparoendoscopic Surgeons.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Society of Laparoendoscopic Surgeons, Inc.</copyright-holder>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="jls00111000127.pdf"/>
      <abstract abstract-type="precis">
        <p>Levonorgestrel-containing intrauterine contraceptive devices may be involved with uterine perforation. The authors note that an experienced gynecological laparoscopist should be able to safely remove an intraperitoneal device without complication.</p>
      </abstract>
      <abstract>
        <p>Levonorgestrel-containing intrauterine contraceptive devices, marketed as <italic>Mirena</italic> (Bayer HealthCare Pharmaceuticals, Inc. Australia) are widely used in contemporary gynecology, primarily as an effective method for contraception and for control of menstrual disorders like menorrhagia and dysmenorrhea. In this article, the authors report 2 cases of Mirena migration following intrauterine insertion by general practitioners (family physicians). In the first case, the contraceptive device had moved to the patient's right iliac fossa just anterior to the cecum and, in the second, within the peritoneal cavity close to the left leaf of the diaphragm. Both patients underwent uneventful laparoscopic retrieval of the devices.</p>
      </abstract>
      <kwd-group>
        <kwd>Mirena</kwd>
        <kwd>Laparoscopic removal</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>SUMMARY OF CLINICAL FEATURES</title>
      <sec>
        <title>Patient One</title>
        <p>CM is a 44-year-old multiparous lady, with children 19 and 17 years of age. She delivered both of her children by spontaneous vaginal deliveries. About 15 months ago, she was fitted with a Mirena for contraception. Regular vaginal examinations by her family physician confirmed that the threads of Mirena were coming off the uterine cervix. She was totally asymptomatic when she went for a periodic cervical smear, at which point this problem with the Mirena device was detected. Ultrasound scan confirmed that the device was not present within the uterine cavity. A computerized tomography scan showed that the device had attached to the posterior aspect of the patient's right rectus sheath. Laparoscopy was performed by using the &#x201C;triple port&#x201D; of entry, and the device was found in the patient's right iliac fossa just above her cecum and was surrounded by omental adhesions. Laparoscopic adhesiolysis was affected to free the device off the omental and cecal adhesions and that was followed by laparoscopic retrieval of the Mirena <bold>(<xref ref-type="fig" rid="F1">Figures 1</xref> and <xref ref-type="fig" rid="F2">2</xref>)</bold>. The procedure was uneventful, and there was no sign of uterine perforation. The patient was discharged after the outpatient procedure.</p>
        <fig id="F1" position="float">
          <label>Figure 1.</label>
          <caption>
            <p>Migrated <italic>Mirena</italic>&#xAE; lying within abdominal cavity on top of the cecum, surrounded by omental adhesions.</p>
          </caption>
          <graphic xlink:href="jls0011127130001"/>
        </fig>
        <fig id="F2" position="float">
          <label>Figure 2.</label>
          <caption>
            <p>Laparoscopic retrieval of the migrated <italic>Mirena</italic>&#xAE; device, following an adhesiolysis procedure.</p>
          </caption>
          <graphic xlink:href="jls0011127130002"/>
        </fig>
      </sec>
      <sec>
        <title>Patient Two</title>
        <p>NG is a 19-year-old single lady. She underwent an unremarkable vaginal suction termination of her first pregnancy (STOP) at about 8 week's gestation and was fitted with a Mirena, at the same time, by the treating physician. She was admitted to the hospital 10 days after the Mirena insertion with a history of acute severe pelvic pain that required administration of narcotic analgesic injections. Ultrasound scanning showed that the uterus was &#x201C;empty.&#x201D; Plain X-ray of the abdomen showed that the Mirena was in the peritoneal cavity close to the pouch of Douglas. Emergency laparoscopy (&#x201C;triple port&#x201D; of entry) was performed, and the peritoneal cavity was carefully inspected. The Mirena was spotted within approximately 3cm of the left leaf of the diaphragm <bold>(<xref ref-type="fig" rid="F3">Figures 3</xref> and <xref ref-type="fig" rid="F4">4</xref>)</bold>. There was no sign of uterine perforation. Laparoscopic removal of the device was carried out smoothly, and the patient was discharged after the outpatient procedure.</p>
        <fig id="F3" position="float">
          <label>Figure 3.</label>
          <caption>
            <p>Migrated <italic>Mirena</italic>&#xAE; is close to the left leaf of the patient's diaphragm.</p>
          </caption>
          <graphic xlink:href="jls0011127130003"/>
        </fig>
        <fig id="F4" position="float">
          <label>Figure 4.</label>
          <caption>
            <p>Laparoscopic retrieval of the migrated <italic>Mirena</italic>&#xAE; device.</p>
          </caption>
          <graphic xlink:href="jls0011127130004"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The levonorgestrel-releasing intrauterine system (LNG-IUS, <italic>Mirena</italic>) is the most widely used contraceptive method, with prevalence rates ranging among countries from 2% to 80% of contraceptive users.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> It releases 20&#x3BC;gm of levonorgestrel/day<sup><xref ref-type="bibr" rid="B2">2</xref></sup> and is used as an effective and reliable method of contraception, to manage menstrual disorders as in menorrhagia<sup><xref ref-type="bibr" rid="B3">3</xref></sup> and dysmenorrhoea,<sup><xref ref-type="bibr" rid="B4">4</xref></sup> as an endometrial protective agent in women using hormonal replacement therapy (HRT),<sup><xref ref-type="bibr" rid="B5">5</xref></sup> and in the management of select cases of endometrial carcinoma<sup><xref ref-type="bibr" rid="B6">6</xref></sup> and precancerous conditions, such as atypical endometrial hyperplasia.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
      <p>As a contraceptive, Mirena is probably the most effective reversible method of contraception<sup><xref ref-type="bibr" rid="B8">8</xref></sup> and without the need to take daily oral medication, as is the case with combined oral contraceptive or progesterone-only pills.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> It is well tolerated, long acting, reversible, and adequately retained within the uterine cavity. Patient satisfaction is high with acceptance among parous and nulliparous women alike, as in the above 2 patients, and it also provides reassuring results for clinicians and adolescents considering use of Mirena.<sup><xref ref-type="bibr" rid="B10">10</xref></sup></p>
      <p>In addition, Mirena is usually recommended as a means of contraception in &#x201C;high risk&#x201D; patients as in those with a history of deep venous thrombosis,<sup><xref ref-type="bibr" rid="B11">11</xref></sup> type 1 diabetes mellitus,<sup><xref ref-type="bibr" rid="B12">12</xref></sup> liver disease,<sup><xref ref-type="bibr" rid="B13">13</xref></sup> epileptic seizures,<sup><xref ref-type="bibr" rid="B14">14</xref></sup> and immunocompromised conditions including HIV.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> Nevertheless, like many therapeutics in contemporary medicine, Mirena has some side effects. Continuing pain and discomfort as well as irregular vaginal bleeding are most likely the main reasons for patients' requests to discontinue the Mirena device therapy.<sup><xref ref-type="bibr" rid="B16">16</xref></sup> Discontinuation is accompanied by return of fertility.<sup><xref ref-type="bibr" rid="B17">17</xref></sup> Contrary to old views, the device does not increase the incidence of pelvic inflammatory disease<sup><xref ref-type="bibr" rid="B18">18</xref></sup> and infertility, nor does it enhance tubal ectopic pregnancies in women with no sexually transmitted infections.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> In fact, Mirena may be considered protective against infection, especially in nulliparous women.<sup><xref ref-type="bibr" rid="B20">20</xref></sup></p>
      <p>Uterine perforation related to the insertion of this device is one of the recognized side effects of Mirena. The incidence of such perforations varies from 0 to 2.6 per 1000 insertions and is largely related to the experience of the operating clinician.<sup><xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref></sup> Expulsion of the device, however, can happen in about 8 per 1000 insertions.<sup><xref ref-type="bibr" rid="B23">23</xref></sup> In case number 1 above, the uterine perforation was thought to have happened more than a year after insertion, because the patient had periodic speculum examinations initially every month for the first 3 months, then followed by 1 speculum exam every 3 months for the subsequent year. The &#x201C;threads&#x201D; of the Mirena device were clearly seen coming off the cervix. The patient remained completely asymptomatic until the device was laparoscopically removed after the threads ceased to be visualized through the cervix. Imaging, especially ultrasonography, has a crucial role in the evaluation and management of intrauterine contraceptive devices and associated complications.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Although it is difficult to be certain of the exact cause of &#x201C;migration&#x201D; of intrauterine contraceptive devices within the peritoneal cavity, a possible mechanism is that the peristalsis of the intestines could well assist this journey within the patient's abdomen after uterine perforation has occurred.</p>
      <p>In case number 2, the patient experienced severe, excruciating pelvic pain, a common symptom of uterine perforation. Interestingly, there was no sign of perforation of the uterus on laparoscopic examination during the Mirena procedure. In relation to the management of this case, one may ask the question: Was it a good idea to insert the intrauterine contraceptive device immediately following STOP (Suction Termination of Pregnancy)? In fact, there is no evidence to support the idea that delayed insertion of the device carries fewer complications.<sup><xref ref-type="bibr" rid="B25">25</xref></sup> Immediate insertion after first- and second-trimester abortions has a high initial continuation and patient satisfaction rate.<sup><xref ref-type="bibr" rid="B26">26</xref></sup> Moreover, this simultaneous therapeutic approach assures the operating clinician and the patient that an unwanted pregnancy in the future is very unlikely with the Mirena device inserted on the same occasion as the termination of pregnancy is to be carried out.<sup><xref ref-type="bibr" rid="B27">27</xref></sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Because Mirena is gaining in popularity among clinicians and enjoys a wide range of candidacy among gynecological patients, it is imperative that health care providers are fully informed of the value as well as the possible side effects of the device, notably uterine perforation. An experienced gynecological endoscopist should be able to safely remove a missed Mirena out of the peritoneal cavity without any complications.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References:</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<collab>ESHRE Capri Workshop Group</collab>
<article-title>Intrauterine devices and intrauterine systems</article-title>. <source>Hum Reprod Update</source>. <year>2008</year>
<season>May-Jun</season>;<volume>14</volume>(<issue>3</issue>):<fpage>197</fpage>&#x2013;<lpage>208</lpage><pub-id pub-id-type="pmid">18400840</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wildemeersch</surname><given-names>D</given-names></name><name><surname>Jansssens</surname><given-names>D</given-names></name><name><surname>Andrade</surname><given-names>A</given-names></name></person-group>
<article-title>The Femilis LNG-IUS: Contraceptive performance- an interim analysis</article-title>. <source>Eur J Contracept Reprod Health Care</source>. <year>2009</year>
<month>4</month>;<volume>14</volume>(<issue>2</issue>):<fpage>103</fpage>&#x2013;<lpage>110</lpage><pub-id pub-id-type="pmid">19340705</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>EC</given-names></name><name><surname>Danis</surname><given-names>PG</given-names></name><name><surname>Tweed</surname><given-names>E</given-names></name></person-group>
<article-title>Clinical inquiries. Menstrual disturbances in perimenopausal women: What's best?</article-title>
<source>J Fam Pract</source>. <year>2009</year>
<month>6</month>;<volume>58</volume>(<issue>6</issue>):<fpage>E3</fpage><pub-id pub-id-type="pmid">19508841</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bahamondes</surname><given-names>L</given-names></name><name><surname>Petta</surname><given-names>CA</given-names></name><name><surname>Fernandes</surname><given-names>A</given-names></name><name><surname>Monteiro</surname><given-names>L</given-names></name></person-group>
<article-title>Use of Levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea</article-title>. <source>Contraception</source>. <year>2007</year>
<month>6</month>;<volume>75</volume>(<issue>6 suppl</issue>):<fpage>S123</fpage>&#x2013;<lpage>S129</lpage><pub-id pub-id-type="pmid">17531603</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cameron</surname><given-names>S</given-names></name></person-group>
<article-title>Contraception and gynaecological care</article-title>. <source>Best Pract Res Clin Obstet Gynaecol</source>. <year>2009</year>
<month>4</month>;<volume>23</volume>(<issue>2</issue>):<fpage>211</fpage>&#x2013;<lpage>220</lpage><pub-id pub-id-type="pmid">19147411</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montz</surname><given-names>FJ</given-names></name><name><surname>Bristow</surname><given-names>RE</given-names></name><name><surname>Bovicelli</surname><given-names>A</given-names></name><name><surname>Tomacruz</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>RJ</given-names></name></person-group>
<article-title>Intrauterine progesterone treatment of early endometrial cancer</article-title>. <source>Am J Obstet Gynecol</source>. <year>2002</year>
<month>4</month>;<volume>186</volume>(<issue>4</issue>):<fpage>651</fpage>&#x2013;<lpage>657</lpage><pub-id pub-id-type="pmid">11967486</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bahamondes</surname><given-names>L</given-names></name><name><surname>Bahamondes</surname><given-names>MV</given-names></name><name><surname>Monteiro</surname><given-names>I</given-names></name></person-group>
<article-title>Levonorgestrel-releasing intrauterine system: uses and controversies</article-title>. <source>Expert Rev Med Devices</source>. <year>2008</year>
<month>7</month>;<volume>5</volume>(<issue>4</issue>):<fpage>437</fpage>&#x2013;<lpage>445</lpage><pub-id pub-id-type="pmid">18573044</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mansour</surname><given-names>D</given-names></name><name><surname>Inki</surname><given-names>P</given-names></name><name><surname>Gemzell-Danielsson</surname><given-names>K</given-names></name></person-group>
<article-title>Efficacy of contraceptive methods: A review of the literature</article-title>. <source>Eur J Contracpt Reprod Health Care</source>. <year>2010</year>
<month>2</month>;<volume>15</volume>(<issue>1</issue>):<fpage>4</fpage>&#x2013;<lpage>16</lpage></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kottke</surname><given-names>M</given-names></name><name><surname>Cwiak</surname><given-names>C</given-names></name></person-group>
<article-title>Non-daily contraceptive options user benefits, potential for high continuation, and counselling issues</article-title>. <source>Obstet Gynecol Surv</source>. <year>2008</year>
<month>10</month>;<volume>63</volume>(<issue>10</issue>):<fpage>661</fpage>&#x2013;<lpage>668</lpage><pub-id pub-id-type="pmid">18799021</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>EM</given-names></name><name><surname>Memmel</surname><given-names>LM</given-names></name><name><surname>Neustadt</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Intrauterine contraception for adolescents aged 14&#x2013;18 years: a multicenter randomised pilot study of Levonorgestrel-releasing intrauterine system compared to the Copper T 380 A</article-title>. <source>Contraception</source>. <year>2010</year>
<month>2</month>;<volume>81</volume>(<issue>2</issue>):<fpage>123</fpage>&#x2013;<lpage>127</lpage><pub-id pub-id-type="pmid">20103449</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Hylckama Vileg</surname><given-names>A</given-names></name><name><surname>Helmerhorst</surname><given-names>FM</given-names></name><name><surname>Vandenbroucke</surname><given-names>JP</given-names></name><name><surname>Doggen</surname><given-names>CJ</given-names></name><name><surname>Rossendaal</surname><given-names>FR</given-names></name></person-group>
<article-title>The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study</article-title>. <source>BMJ</source>. <year>2009</year>
<month>8</month>
<day>13</day>;<volume>339</volume>:<fpage>b 2921</fpage></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rogovskaya</surname><given-names>S</given-names></name><name><surname>Rivera</surname><given-names>R</given-names></name><name><surname>Grimes</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>Effect of a Levonorgestrel intrauterine system on women with type 1 diabetes: a randomised trial</article-title>. <source>Obstet Gynecol</source>. <year>2005</year>
<month>4</month>;<volume>105</volume>(<issue>4</issue>):<fpage>811</fpage>&#x2013;<lpage>815</lpage><pub-id pub-id-type="pmid">15802410</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>TJ</given-names></name><name><surname>Zuckerman</surname><given-names>AL</given-names></name></person-group>
<article-title>Contraception in the patient with liver disease</article-title>. <source>Semin Perinatol</source>. <year>1998</year>
<month>4</month>;<volume>22</volume>(<issue>2</issue>):<fpage>178</fpage>&#x2013;<lpage>182</lpage><pub-id pub-id-type="pmid">9638912</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwenkhagen</surname><given-names>AM</given-names></name><name><surname>Stodieck</surname><given-names>SR</given-names></name></person-group>
<article-title>Which contraception for women with epilepsy?</article-title>
<source>Seizure</source>. <year>2008</year>
<month>3</month>;<volume>17</volume>(<issue>2</issue>):<fpage>145</fpage>&#x2013;<lpage>150</lpage><pub-id pub-id-type="pmid">18178110</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steen</surname><given-names>R</given-names></name><name><surname>Shapiro</surname><given-names>K</given-names></name></person-group>
<article-title>Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings</article-title>. <source>Reprod Health Matters</source>. <year>2004</year>
<month>5</month>;<volume>12</volume>(<issue>23</issue>):<fpage>138</fpage>&#x2013;<lpage>143</lpage></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Backman</surname><given-names>T</given-names></name></person-group>
<article-title>Benefit-risk assessment of the Levonorgestrel intrauterine system in contraception</article-title>. <source>Drug Saf</source>. <year>2004</year>;<volume>271</volume>(<issue>15</issue>):<fpage>1185</fpage>&#x2013;<lpage>1204</lpage><pub-id pub-id-type="pmid">15588115</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mishell</surname><given-names>Dr</given-names><suffix>Jr.</suffix></name><name><surname>Sulak</surname><given-names>PJ</given-names></name></person-group>
<article-title>The IUD: dispelling the myths and assessing the potential</article-title>. <source>Dialogues Contracept</source>. <year>1997</year>
<comment>Spring</comment>;<volume>5</volume>(<issue>2</issue>):<fpage>1</fpage>&#x2013;<lpage>4</lpage></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimoni</surname><given-names>N</given-names></name></person-group>
<article-title>Intrauterine contraceptives: a review of uses, side effects, and candidates</article-title>. <source>Semin Reprod Med</source>. <year>2010</year>
<month>3</month>;<volume>28</volume>(<issue>2</issue>):<fpage>118</fpage>&#x2013;<lpage>256</lpage><pub-id pub-id-type="pmid">20352561</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gold</surname><given-names>MA</given-names></name><name><surname>Johnson</surname><given-names>LM</given-names></name></person-group>
<article-title>Intrauterine devices and adolescents</article-title>. <source>Curr Opin Obstet Gynecol</source>. <year>2008</year>
<month>10</month>;<volume>20</volume>(<issue>5</issue>):<fpage>464</fpage>&#x2013;<lpage>469</lpage><pub-id pub-id-type="pmid">18797269</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prager</surname><given-names>S</given-names></name><name><surname>Damey</surname><given-names>PD</given-names></name></person-group>
<article-title>The Levonorgestrel intrauterine system in nulliparous women</article-title>. <source>Contraception</source>. <year>2007</year>
<month>6</month>;<volume>75</volume> (<issue>6 Suppl</issue>):<fpage>S12</fpage>&#x2013;<lpage>S15</lpage><pub-id pub-id-type="pmid">17531602</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pappas</surname><given-names>A</given-names></name><name><surname>Shambhu</surname><given-names>S</given-names></name><name><surname>Phillips</surname><given-names>K</given-names></name><name><surname>Guthrie</surname><given-names>K</given-names></name></person-group>
<article-title>A Levonorgestrel-releasing intrauterine system embedded in the omentum in a woman with abdominal pain: a case report</article-title>. <source>J Med Case Reports</source>. <year>2009</year>
<month>11</month>;<volume>3</volume>:<fpage>9301</fpage><pub-id pub-id-type="pmid">20062790</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Houdenhoven</surname><given-names>K</given-names></name><name><surname>van Kaam</surname><given-names>KJ</given-names></name><name><surname>van Grootheest</surname><given-names>AC</given-names></name><name><surname>Salemans</surname><given-names>TH</given-names></name><name><surname>Dunselman</surname><given-names>GA</given-names></name></person-group>
<article-title>Uterine perforation in women using a Levonorgestrel-releasing intrauterine system</article-title>. <source>Contraception</source>. <year>2006</year>
<month>3</month>;<volume>73</volume>(<issue>3</issue>):<fpage>257</fpage>&#x2013;<lpage>270</lpage><pub-id pub-id-type="pmid">16472566</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paterson</surname><given-names>H</given-names></name><name><surname>Ashton</surname><given-names>J</given-names></name><name><surname>Harrison-Woolrych</surname><given-names>M</given-names></name></person-group>
<article-title>A nationwide cohort study of the use of the Levonorgestrel intrauterine device in New Zealand adolescents</article-title>. <source>Contraception</source>. <year>2009</year>
<month>6</month>;<volume>79</volume>(<issue>6</issue>):<fpage>433</fpage>&#x2013;<lpage>438</lpage><pub-id pub-id-type="pmid">19442778</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peri</surname><given-names>N</given-names></name><name><surname>Graham</surname><given-names>D</given-names></name><name><surname>Levine</surname><given-names>D</given-names></name></person-group>
<article-title>Imaging of intrauterine contraceptive devices</article-title>. <source>J Ultrasound Med</source>. <year>2007</year>
<month>10</month>;<volume>26</volume>(<issue>16</issue>):<fpage>1389</fpage>&#x2013;<lpage>1401</lpage><pub-id pub-id-type="pmid">17901142</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kapp</surname><given-names>N</given-names></name><name><surname>Curtis</surname><given-names>KM</given-names></name></person-group>
<article-title>Intrauterine device insertion during the postpartum period: a systematic review</article-title>. <source>Contraception</source>. <year>2009</year>
<month>10</month>;<volume>80</volume>(<issue>4</issue>):<fpage>327</fpage>&#x2013;<lpage>336</lpage><pub-id pub-id-type="pmid">19751855</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drey</surname><given-names>EA</given-names></name><name><surname>Reeves</surname><given-names>MF</given-names></name><name><surname>Ogawa</surname><given-names>DD</given-names></name><name><surname>Scholoff</surname><given-names>A</given-names></name><name><surname>Darney</surname><given-names>PD</given-names></name><name><surname>Steinauer</surname><given-names>JE</given-names></name></person-group>
<article-title>Insertion of intrauterine contraceptives immediately following first-and second-trimester abortions</article-title>. <source>Contraception</source>. <year>2009</year>
<month>5</month>;<volume>79</volume>(<issue>5</issue>):<fpage>397</fpage>&#x2013;<lpage>402</lpage><pub-id pub-id-type="pmid">19341854</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grimes</surname><given-names>D</given-names></name><name><surname>Sculz</surname><given-names>K</given-names></name><name><surname>Stanwood</surname><given-names>N</given-names></name></person-group>
<article-title>Immediate postabortal insertion of intrauterine devices</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2004</year>
<month>10</month>;<volume>18</volume>(<issue>4</issue>):<fpage>CDOO1777</fpage></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
